Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
Author:
Funder
AstraZeneca
MSD K.K.
Bristol-Myers Squibb
Ono pharmaceutical
Chugai Pharmaceutical
Eli Lilly Japan
Astellas Pharma
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-019-01424-y.pdf
Reference56 articles.
1. Toyoda Y, Nakayama T, Ioka A et al (2008) Trend in lung cancer incidence by histological type in Osaka, Japan. Jpn J Clin Oncol 38:534–539
2. National Cancer Institute: SEER Cancer Statistics Review: Available via DIALOG https://seer.cancer.gov/ . Accessed May 2018
3. Hotta K, Matsuo K, Ueoka H et al (2004) Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22:3852–3859
4. Hotta K, Matsuo K, Ueoka H et al (2004) Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials. Ann Oncol 15:1782–1789
5. Hotta K, Matsuo K (2007) Long-standing debate on cisplatin- versus carboplatin-based chemotherapy in the treatment of advanced non-small-cell lung cancer. J Thorac Oncol 2:96
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy;Journal of Nanoparticle Research;2024-05
2. Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma;Molecular and Clinical Oncology;2023-07-06
3. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma;Scientific Reports;2022-08-11
4. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway;Tissue and Cell;2022-06
5. LncRNA PITPNA‐AS1 / miR ‐223‐3p/ PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma;Journal of Clinical Laboratory Analysis;2022-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3